Fennec Pharmaceuticals Inc. (FENC) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$7.3
Day's range
$8

Fennec Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ROSALIND ADVISORS, INC. 05/14/2026 2.91 M $17.89 M   11.28% 10.18%
SOUTHPOINT CAPITAL ADVISORS LP 05/15/2026 2.74 M $16.88 M   0.00% 9.60%
SOLAS CAPITAL MANAGEMENT, LLC 05/15/2026 2.48 M $15.27 M   -3.07% 8.69%
AIGH CAPITAL MANAGEMENT LLC 04/30/2026 1.98 M $12.19 M   25.29% 6.93%
BLACKROCK, INC. 05/13/2026 1.37 M $8.41 M   10.85% 4.79%
05/15/2026 897.14 K $5.52 M   100.00% 3.14%
AWM INVESTMENT COMPANY, INC. 05/15/2026 720.14 K $4.43 M   1.16% 2.52%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 371.74 K $2.29 M   25.12% 1.30%
STATE STREET CORP 05/15/2026 359.06 K $2.21 M   1.78% 1.26%
POTOMAC CAPITAL MANAGEMENT, INC. 05/14/2026 224.40 K $1.38 M   135.96% 0.79%
MORGAN STANLEY 05/15/2026 211.11 K $1.30 M   -12.94% 0.74%
05/08/2026 168.47 K $1.04 M   100.00% 0.59%
CITADEL ADVISORS LLC 05/15/2026 153.61 K $944.70 K   -23.10% 0.54%
NORTHERN TRUST CORP 05/14/2026 152.12 K $935.56 K   35.71% 0.53%
LION POINT CAPITAL, LP 05/15/2026 112.43 K $691.47 K   0.00% 0.39%
CORNERSTONE CAPITAL, INC. 05/12/2026 105.00 K $645.75 K   100.00% 0.37%
GENDELL JEFFREY L 05/15/2026 83.02 K $510.60 K   -40.51% 0.29%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2026 83.01 K $510.48 K   0.00% 0.29%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 63.54 K $390.75 K   10.98% 0.22%
NUVEEN, LLC 04/30/2026 60.95 K $374.83 K   134.36% 0.21%
THOMPSON SIEGEL & WALMSLEY LLC 05/11/2026 57.23 K $352.00 K   100.00% 0.20%
SQUAREPOINT OPS LLC 05/15/2026 56.51 K $347.54 K   331.08% 0.20%
GOLDMAN SACHS GROUP INC 05/15/2026 55.66 K $342.33 K   27.70% 0.19%
ELEVA CAPITAL SAS 04/15/2026 53.23 K $327.39 K   100.00% 0.19%
BANK OF NEW YORK MELLON CORP 05/05/2026 52.46 K $322.64 K   6.59% 0.18%
TREXQUANT INVESTMENT LP 05/15/2026 51.87 K $318.99 K   0.95% 0.18%
1492 CAPITAL MANAGEMENT LLC 04/22/2026 50.71 K $311.84 K   80.50% 0.18%
HARTFORD FINANCIAL MANAGEMENT INC. 04/16/2026 50.65 K $311.47 K   0.00% 0.18%
STATE OF WISCONSIN INVESTMENT BOARD 05/15/2026 43.50 K $267.53 K   -14.71% 0.15%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 38.72 K $238.15 K   100.00% 0.14%
RHUMBLINE ADVISERS 05/12/2026 31.30 K $192.48 K   7.78% 0.11%
PRELUDE CAPITAL MANAGEMENT, LLC 05/15/2026 29.60 K $182.03 K   100.00% 0.10%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 29.38 K $180.68 K   -34.27% 0.10%
BANK OF AMERICA CORP /DE/ 05/18/2026 26.41 K $162.39 K   17.18% 0.09%
JONES FINANCIAL COMPANIES LLLP 05/15/2026 24.95 K $147.47 K   0.00% 0.09%
AQR CAPITAL MANAGEMENT LLC 05/15/2026 24.15 K $148.50 K   59.50% 0.08%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 22.40 K $137.76 K   100.00% 0.08%
NANO CAP NEW MILLENNIUM GROWTH FUND L P 05/15/2026 21.50 K $132.23 K   100.00% 0.08%
DEUTSCHE BANK AG\ 05/06/2026 21.20 K $130.39 K   22.10% 0.07%
GLOBEFLEX CAPITAL L P 05/13/2026 18.34 K $112.81 K   100.00% 0.06%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 16.87 K $104.00 K   34.88% 0.06%
ENGINEERS GATE MANAGER LP 05/15/2026 15.52 K $95.42 K   100.00% 0.05%
XTX TOPCO LTD 05/15/2026 15.26 K $93.82 K   -43.05% 0.05%
HIGHTOWER ADVISORS, LLC 05/05/2026 14.96 K $92.00 K   -0.27% 0.05%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 05/15/2026 13.62 K $83.77 K   25.27% 0.05%
METLIFE INVESTMENT MANAGEMENT, LLC 05/14/2026 13.51 K $83.08 K   3.76% 0.05%
JPMORGAN CHASE & CO 05/13/2026 11.86 K $68.43 K   21.37% 0.04%
INVESCO LTD. 05/12/2026 11.68 K $71.81 K   -18.50% 0.04%
WELLS FARGO & COMPANY/MN 05/11/2026 10.90 K $67.02 K   -58.34% 0.04%
ALLIANCEBERNSTEIN L.P. 05/15/2026 10.31 K $79.39 K   0.00% 0.04%

Fennec Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 120 institutional investors and hedge funds held shares of Fennec Pharmaceuticals Inc. The most heavily invested institutionals were:

Rosalind Advisors, Inc.: 2.91 M

Southpoint Capital Advisors LP: 2.74 M

Solas Capital Management, LLC: 2.48 M

AIGH Capital Management LLC: 1.98 M

BlackRock, Inc.: 1.37 M

AWM Investment Company, Inc.: 720,135

56.69% of Fennec Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 23.21 M shares in the last 24 months. This purchase volume represents approximately $176.19 M in transactions.